Trudell Medical Limited expanding into respiratory diagnostics with agreement to acquire Vyaire Medical RDx
Trudell Medical Limited has reached an agreement to purchase the RDx business unit of Vyaire Medical.
RDx manufactures respiratory diagnostic products that are used in hospitals and private clinics worldwide and are trusted by specialists in the respiratory community to help enable, enhance and extend lives.
The purchase is subject to court approval and is expected to close in 8-12 weeks. The acquisition will expand Trudell Medical’s already strong market position in aerosol drug delivery and lung health devices to include respiratory diagnostics.
Trudell Medical intends to operate RDx as a separate business unit and maintain operations in Germany and California.
The acquisition would ensure the continuation of service to RDx customers. Earlier this year, Vyaire Medical filed for Chapter 11 Protection and announced the company was focused on selling its business units to stable, well-capitalized buyers to support the growth and development of their business units.
Vyaire’s Repiratory Diagnostics and Ventilation solutions are currently distributed by Trudell Healthcare Solutions (THS) within the Canadian healthcare system. THS is a leading distributor of innovative solutions that improve patient outcomes.
Quotes
“We welcome the opportunity to add Vyaire RDx’s people, products, and passion to our Trudell Medical family. Respiratory Diagnostics help to enable, enhance, and extend lives. This is in perfect alignment with our ‘Patient First’ Core Value across the Trudell Medical Group. Every day, we’re focused on designing and manufacturing products and services that improve patients’ lives.”
-George Baran, Executive Chair, Trudell Medical Limited
“As leaders in respiratory health, we are very familiar with Vyaire RDx products, which are among the most trusted by specialists in pulmonary health. This is an exciting acquisition that will expand our footprint into respiratory diagnostics while propelling our long-term growth strategy.”
-Gerald Slemko, CEO, Trudell Medical Limited
"Since establishing the market 70 years ago under Eric Jaeger's leadership, Vyaire RDx has been a global leader in the Pulmonary Function Testing space. As part of this legacy, Trudell have been an oustanding distribution partner for Vyaire RDx in Canada. This well-established relationship serves as a firm foundation for Vyaire RDx to become part of the Trudell family, which has clearly aligned values and shared business objectives built on placing the customer and our employees at the heart of all we do. The entire RDx team are excited about the next stage of our journey as we continue to deliver innovative, market leading products to our customers around the world."
-Will Throp, CEO, Vyaire RDx
About Trudell Medical Limited
Our focus is on respiratory care, select areas of the hospital operating room and providing pathways for virtual care. Our vision is to provide patients throughout the world with medical devices and services that make their lives better.
Over the years the Trudell Medical Group has grown to a family of six operating companies that are overseen and supported by Trudell Medical Limited, our corporate entity. Trudell Medical Limited has been named one of Canada’s Best Managed Companies three years in a row.
Visit TrudellMedicalGroup.com for more information.
About Respiratory Diagnostics (RDx)
Established from legacy brands with a 70-year history of pioneering breathing technology, Vyaire RDx has a rich history of thinking forward and bringing cutting-edge solutions to the caregivers and patients we serve. Our vision is to be the foremost global leader in respiratory diagnostics, providing customers in over 100 countries with innovative and integrated solutions that improve patient lives. Learn more about Vyaire RDx.
For more information, please contact:
Adam Nyp
Digital Communications Specialist
1-226-577-9623
adam.nyp@tmlcorp.com
